Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells

International Journal of Molecular Medicine

Volumn 34, Issue 4, 2014, Pages 941-946

  Guerrero Preston, Rafael ^a,b   Ogawa, Takenori ^a   Uemura, Mamoru ^a   Shumulinsky, Gary ^a   Valle, Blanca L ^a   Pirini, Francesca ^a   Ravi, Rajani ^a   Sidransky, David ^a   Keidar, Michael ^c   Trink, Barry ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^c George Washington University   (United States)

Author keywords

Cold atmospheric plasma selectivity; Cold atmospheric plasma treatment; Head and neck squamous cell carcinoma; Head and neck squamous cell carcinoma adjuvant treatment; HPV negative head and neck squamous cell carcinoma; HPV positive head and neck squamous cell carcinoma

Indexed keywords

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER THERAPY; CELL VIABILITY; CLONOGENIC ASSAY; COLD ATMOSPHERIC PLASMA; COLD ATMOSPHERIC PLASMA TREATMENT; COLONY FORMATION; CONTROLLED STUDY; EPITHELIUM CELL; HEAD AND NECK SQUAMOUS CELL CARCINOMA; IN VITRO STUDY; MOUTH CAVITY; MTT ASSAY; PLASMA GAS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA CELL; TARGET CELL; TREATMENT DURATION; TUMOR ABLATION; ATMOSPHERE; CELL SURVIVAL; DRUG EFFECTS; DRUG SCREENING; HEAD AND NECK TUMOR; HUMAN; METABOLISM; PATHOLOGY; PHARMACOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; WESTERN BLOTTING;

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLASMA GAS;

ATMOSPHERE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; HEAD AND NECK NEOPLASMS; HUMANS; PLASMA GASES; POLY(ADP-RIBOSE) POLYMERASES; TUMOR STEM CELL ASSAY;

EID: 84907469761     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1849     Document Type: Article

References (41)

1. Agrawal N, Frederick MJ, Pickering CR, et al: Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333: 1154-1157, 2011.
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007. (Pubitemid 46148091)
3. Fletcher EV: Epidermal growth factor receptor inhibitor induces interleukin-6 via NADPH oxidase enzymes in head and neck cancer cells. Master's thesis, University of Iowa, 2012.
4. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349: 2091-2098, 2003. (Pubitemid 37464533)
5. Hardisson D: Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260: 502-508, 2003.
6. Wang M, Holmes B, Cheng X, et al: Cold atmospheric plasma for selectively ablating metastatic breast cancer cells. PLoS One 8: e73741, 2013.
7. Shimizu T, Steffes B, Pompl R, et al: Characterization of microwave plasma torch for decontamination. Plasma Process Polym 5: 577-582, 2008.
8. Yonson S, Coulombe S, Léveillé V and Leask RL: Cell treatment and surface functionalization using a miniature atmospheric pressure glow discharge plasma torch. J Phys D Appl Phys 39: 3508-3513, 2008.
9. Kim JY, Ballato J, Foy P, et al: Single-cell-level cancer therapy using a hollow optical fiber-based microplasma. Small 6: 1474-1478, 2010.
10. Lupu AR, Georgescu N, Cǎlugǎru A, et al: The effects of cold atmospheric plasma jets on B16 and COLO320 tumoral cells. Roum Arch Microbiol Immunol 68: 136-144, 2009.
11. Lupu AR and Georgescu N: Cold atmospheric plasma jet effects on V79-4 cells. Roum Arch Microbiol Immunol 69: 67-74, 2010.
12. Moisan M, Barbeau J, Moreau S, et al: Low-temperature sterilization using gas plasmas: a review of the experiments and an analysis of the inactivation mechanisms. Int J Pharm 226: 1-21, 2001. (Pubitemid 32800778)
13. Kim JY, Ballato J, Foy P, et al: Apoptosis of lung carcinoma cells induced by a flexible optical fiber-based cold microplasma. Biosens Bioelectron 28: 333-338, 2011.
14. Panngom K, Baik KY, Nam MK, et al: Preferential killing of human lung cancer cell lines with mitochondrial dysfunction by nonthermal dielectric barrier discharge plasma. Cell Death Dis 4: e642, 2013.
15. Keidar M, Walk R, Shashurin A, et al: Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br J Cancer 105: 1295-1301, 2011.
16. Hoffmann M, Bruch HP, Kujath P and Limmer S: Cold-plasma coagulation in the treatment of malignant pleural mesothelioma: results of a combined approach. Interact Cardiovasc Thorac Surg 10: 502-505, 2010.
17. Walk RM, Snyder JA, Srinivasan P, et al: Cold atmospheric plasma for the ablative treatment of neuroblastoma. J Pediatr Surg 48: 67-73, 2013.
18. Volotskova O, Hawley TS, Stepp MA and Keidar M: Targeting the cancer cell cycle by cold atmospheric plasma. Sci Rep 2: 636, 2012.
19. Sensenig R, Kalghatgi S, Cerchar E, et al: Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species. Ann Biomed Eng 39: 674-687, 2011.
20. Vandamme M, Robert E, Lerondel S, et al: ROS implication in a new antitumor strategy based on non-thermal plasma. Int J Cancer 130: 2185-2194, 2012.
21. Arndt S, Wacker E, Li YF, et al: Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells. Exp Dermatol 22: 284-289, 2013.
22. Sandulache VC, Ow TJ, Daram SP, et al: Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: association with locoregional recurrence, distant metastasis, and decreased survival. Head Neck 35: 1454-1460, 2013.
23. Kieft IE, Kurdi M and Stoffels E: Reattachment and apoptosis after plasma-needle treatment of cultured cells. IEEE T Plasma Sci 34: 1331-1336, 2006. (Pubitemid 44283329)
24. Lee HJ, Shon CH, Kim YS, et al: Degradation of adhesion molecules of G361 melanoma cells by a non-thermal atmospheric pressure microplasma. New J Phys 11: 115026, 2009.
25. Shashurin A, Stepp MA, Hawley TS, et al: Influence of cold plasma atmospheric jet on surface integrin expression of living cells. Plasma Process Polym 7: 294-300, 2010.
26. Keidar M, Shashurin A, Volotskova O, et al: Cold atmospheric plasma in cancer therapy. Physics of Plasmas 20: 057101, 2013.
27. Vandamme M, Robert E, Pesnel S, et al: Antitumor effect of plasma treatment on U87 glioma xenografts: preliminary results. Plasma Process Polym 7: 264-273, 2010.
28. Skinner HD, Sandulache VC, Ow TJ, et al: TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res 18: 290-300, 2012.
29. Tokumaru Y, Yamashita K, Osada M, et al: Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res 64: 5982-5987, 2004. (Pubitemid 39129394)
30. Gu X, Song X, Dong Y, et al: Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 14: 1840-1848, 2008. (Pubitemid 351469471)
31. Burns JE, Baird MC, Clark LJ, et al: Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 67: 1274-1284, 1993. (Pubitemid 23172865)
32. Ho AS, Kraus DH, Ganly I, et al: Decision making in the management of recurrent head and neck cancer. Head Neck 36: 144-151, 2014.
33. Strojan, P, Corry J, Eisbruch A, et al: Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck: Nov 7, 2013 (Epub ahead of print).
34. Mehanna HM and Ang KK: Head and Neck Cancer Recurrence: Evidence-based Multidisciplinary Management. 1st edition. Thieme Medical Publishers, Inc., New York, NY, p316, 2012.
35. Hoffmann TK: Systemic therapy strategies for head-neck carcinomas: current status. GMS Curr Top Otorhinolaryngol Head Neck Surg 11: Doc03, 2012.
36. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354: 567-578, 2006. (Pubitemid 43209104)
37. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35, 2010.
38. Kelloff GJ, Lippman SM, Dannenberg AJ, et al: Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward. Clin Cancer Res 12: 3661-3697, 2006. (Pubitemid 44000248)
39. Myers MF, Chang MH, Jorgensen C, et al: Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices. Genet Med 8: 361-370, 2006. (Pubitemid 44297307)
40. Whitworth A: New research suggests access, genetic differences play role in high minority cancer death rate. J Natl Cancer Inst 98: 669, 2006.
41. Svatek RS, Lee JJ, Roehrborn CG, Lippman SM and Lotan Y: The cost of prostate cancer chemoprevention: a decision analysis model. Cancer Epidemiol Biomarkers Prev 15: 1485-1489, 2006. (Pubitemid 44299320)